- Home
- FBRT vs ORIC Comparison
FBRT vs ORIC Comparison
Compare FBRT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- ORIC
- Stock Information
- Founded
- FBRT 2012
- ORIC 2014
- Country
- FBRT United States
- ORIC United States
- Employees
- FBRT N/A
- ORIC N/A
- Industry
- FBRT Real Estate Investment Trusts
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FBRT Real Estate
- ORIC Health Care
- Exchange
- FBRT Nasdaq
- ORIC Nasdaq
- Market Cap
- FBRT 859.1M
- ORIC 940.8M
- IPO Year
- FBRT 1985
- ORIC 2020
- Fundamental
- Price
- FBRT $10.47
- ORIC $10.12
- Analyst Decision
- FBRT Strong Buy
- ORIC Strong Buy
- Analyst Count
- FBRT 5
- ORIC 9
- Target Price
- FBRT $15.10
- ORIC $18.29
- AVG Volume (30 Days)
- FBRT 613.8K
- ORIC 1.2M
- Earning Date
- FBRT 07-30-2025
- ORIC 08-11-2025
- Dividend Yield
- FBRT 13.73%
- ORIC N/A
- EPS Growth
- FBRT 18.52
- ORIC N/A
- EPS
- FBRT 0.98
- ORIC N/A
- Revenue
- FBRT $207,768,000.00
- ORIC N/A
- Revenue This Year
- FBRT $28.21
- ORIC N/A
- Revenue Next Year
- FBRT $2.40
- ORIC N/A
- P/E Ratio
- FBRT $10.56
- ORIC N/A
- Revenue Growth
- FBRT 16.05
- ORIC N/A
- 52 Week Low
- FBRT $9.79
- ORIC $3.90
- 52 Week High
- FBRT $13.74
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- FBRT 46.04
- ORIC 43.96
- Support Level
- FBRT $9.79
- ORIC $10.00
- Resistance Level
- FBRT $10.68
- ORIC $11.62
- Average True Range (ATR)
- FBRT 0.26
- ORIC 0.63
- MACD
- FBRT -0.03
- ORIC -0.24
- Stochastic Oscillator
- FBRT 56.20
- ORIC 20.68
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.